114 related articles for article (PubMed ID: 31692899)
1. Correction: Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway.
Ouyang Z; Guo X; Chen X; Liu B; Zhang Q; Yin Z; Zhai Z; Qu X; Liu X; Peng D; Shen Y; Liu T; Zhang Q
Oncotarget; 2019 Oct; 10(58):6283-6284. PubMed ID: 31692899
[TBL] [Abstract][Full Text] [Related]
2. Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway.
Ouyang Z; Guo X; Chen X; Liu B; Zhang Q; Yin Z; Zhai Z; Qu X; Liu X; Peng D; Shen Y; Liu T; Zhang Q
Oncotarget; 2018 Jan; 9(2):1868-1884. PubMed ID: 29416737
[TBL] [Abstract][Full Text] [Related]
3. Correction: Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis
Yang H; Guan L; Li S; Jiang Y; Xiong N; Li L; Wu C; Zeng H; Liu Y
Oncotarget; 2018 Aug; 9(66):32730. PubMed ID: 30220978
[TBL] [Abstract][Full Text] [Related]
4. Piperine alleviates osteoclast formation through the p38/c-Fos/NFATc1 signaling axis.
Deepak V; Kruger MC; Joubert A; Coetzee M
Biofactors; 2015; 41(6):403-13. PubMed ID: 26627060
[TBL] [Abstract][Full Text] [Related]
5. Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway.
Ouyang Z; Zhai Z; Li H; Liu X; Qu X; Li X; Fan Q; Tang T; Qin A; Dai K
Biochem Pharmacol; 2014 Aug; 90(3):276-87. PubMed ID: 24950468
[TBL] [Abstract][Full Text] [Related]
6. Orostachys japonicus Suppresses Osteoclast Differentiation by Inhibiting NFATc1 Expression.
Shim KS; Ha H; Kim T; Lee CJ; Ma JY
Am J Chin Med; 2015; 43(5):1013-30. PubMed ID: 26205967
[TBL] [Abstract][Full Text] [Related]
7. Dectin-1 signaling inhibits osteoclastogenesis via IL-33-induced inhibition of NFATc1.
Zhu X; Zhao Y; Jiang Y; Qin T; Chen J; Chu X; Yi Q; Gao S; Wang S
Oncotarget; 2017 Aug; 8(32):53366-53374. PubMed ID: 28881817
[TBL] [Abstract][Full Text] [Related]
8. Correction: Loss of EGFR signaling-regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.
Siu MK; Abou-Kheir W; Yin JJ; Chang YS; Barrett B; Suau F; Casey O; Chen WY; Fang L; Hynes P; Hsieh YY; Liu YN; Huang J; Kelly K
Oncotarget; 2018 Aug; 9(64):32403. PubMed ID: 30190798
[TBL] [Abstract][Full Text] [Related]
9. Correction: 2'-Hydroxyflavanone effectively targets RLIP76-mediated drug transport and regulates critical signaling networks in breast cancer.
Nagaprashantha LD; Singhal J; Li H; Warden C; Liu X; Horne D; Awasthi S; Salgia R; Singhal SS
Oncotarget; 2022; 13():331. PubMed ID: 35261722
[TBL] [Abstract][Full Text] [Related]
10. Correction: Resistin promotes tumor metastasis by down-regulation of miR-519d through the AMPK/p38 signaling pathway in human chondrosarcoma cells.
Tsai CH; Tsai HC; Huang HN; Hung CH; Hsu CJ; Fong YC; Hsu HC; Huang YL; Tang CH
Oncotarget; 2018 Oct; 9(85):35598. PubMed ID: 30473753
[TBL] [Abstract][Full Text] [Related]
11. Nitidine chloride prevents OVX-induced bone loss via suppressing NFATc1-mediated osteoclast differentiation.
Liu Q; Wang T; Zhou L; Song F; Qin A; Feng HT; Lin XX; Lin Z; Yuan JB; Tickner J; Liu HG; Zheng MH; Xu J; Zhao JM
Sci Rep; 2016 Nov; 6():36662. PubMed ID: 27821837
[TBL] [Abstract][Full Text] [Related]
12. Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade.
Moon JB; Kim JH; Kim K; Youn BU; Ko A; Lee SY; Kim N
J Immunol; 2012 Jan; 188(1):163-9. PubMed ID: 22131333
[TBL] [Abstract][Full Text] [Related]
13. SREBP-2 aggravates breast cancer associated osteolysis by promoting osteoclastogenesis and breast cancer metastasis.
Jie Z; Xie Z; Xu W; Zhao X; Jin G; Sun X; Huang B; Tang P; Wang G; Shen S; Qin A; Fan S
Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):115-125. PubMed ID: 30394316
[TBL] [Abstract][Full Text] [Related]
14. Purslane suppresses osteoclast differentiation and bone resorbing activity via inhibition of Akt/GSK3β-c-Fos-NFATc1 signaling in vitro and prevents lipopolysaccharide-induced bone loss in vivo.
Kim JY; Oh HM; Kwak SC; Cheon YH; Lee MS; Rho MC; Oh J
Biol Pharm Bull; 2015; 38(1):66-74. PubMed ID: 25744460
[TBL] [Abstract][Full Text] [Related]
15. Artesunate suppresses RANKL-induced osteoclastogenesis through inhibition of PLCγ1-Ca
Zeng X; Zhang Y; Wang S; Wang K; Tao L; Zou M; Chen N; Xu J; Liu S; Li X
Biochem Pharmacol; 2017 Jan; 124():57-68. PubMed ID: 27789216
[TBL] [Abstract][Full Text] [Related]
16. Gastrodin inhibits osteoclastogenesis via down-regulating the NFATc1 signaling pathway and stimulates osseointegration in vitro.
Zhou F; Shen Y; Liu B; Chen X; Wan L; Peng D
Biochem Biophys Res Commun; 2017 Mar; 484(4):820-826. PubMed ID: 28161640
[TBL] [Abstract][Full Text] [Related]
17. Correction: TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.
Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z
Oncotarget; 2019 Nov; 10(60):6540. PubMed ID: 31741718
[TBL] [Abstract][Full Text] [Related]
18. Correction: Neoadjuvant olaparib targets hypoxia to improve radioresponse in a homologous recombination-proficient breast cancer model.
Borst GR; Kumareswaran R; Yücel H; Telli S; Do T; McKee T; Zafarana G; Jonkers J; Verheij M; O'Connor MJ; Rottenberg S; Bristow RG
Oncotarget; 2020 Apr; 11(17):1573-1574. PubMed ID: 32391125
[TBL] [Abstract][Full Text] [Related]
19. Nur77 prevents excessive osteoclastogenesis by inducing ubiquitin ligase Cbl-b to mediate NFATc1 self-limitation.
Li X; Wei W; Huynh H; Zuo H; Wang X; Wan Y
Elife; 2015 Jul; 4():e07217. PubMed ID: 26173181
[TBL] [Abstract][Full Text] [Related]
20. Correction: Hypoxia/reoxygenation-experienced cancer cell migration and metastasis are regulated by Rap1- and Rac1-GTPase activation
Lee JW; Ryu YK; Ji YH; Kang JH; Moon EY
Oncotarget; 2018 Dec; 9(101):37608-37609. PubMed ID: 30680073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
